Net Cash Provided by (Used in) Operating Activities |
-10.7K |
USD |
-22256% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
10.7K |
USD |
+14208% |
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
290M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
93.3K |
shares |
-100% |
Q2 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
27 |
USD |
|
Q4 2022 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.09K |
USD |
|
Q1 2023 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
59.5K |
USD |
+20.9% |
Q2 2024 |
Q3 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.35 |
pure |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
170K |
USD |
+20.9% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Additional Paid in Capital |
74.7K |
USD |
+43.1% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Current Federal Tax Expense (Benefit) |
34.9K |
USD |
+26.2% |
Q1 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |